P. Gous

Phase 3, Randomized, 20-Month Study of the Efficacy and Safety of Bimatoprost Implant in Patients with Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 2)

Dawn Y. Lim, John C. Greiner, H. Thieme, 2021, Drugs.

A comparative trial of the safety and efficacy of 0.1 percent pemirolast potassium ophthalmic solution dosed twice or four times a day in patients with seasonal allergic conjunctivitis.

A. Ropo, P. Gous, 2004, Journal of Ocular Pharmacology and Therapeutics.